Retina/Vitreous News

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Joan Stauffer, director of marketing and communications for Iridex, discusses new laser systems from the company.

The prevalence of myopic macular degeneration among very old individuals increased nearly ninefold for each millimeter increase in axial length and was strongly associated with vision impairment and blindness, according to a study.

The first quarter of 2024 has come to a close, but Healio’s ophthalmology meeting news coverage is just getting started.

CMS has assigned a permanent J-code for Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Iveric Bio.

Dosing is complete in the first cohort of the phase 1/2 clinical trial of OPGx-LCA5 for the treatment of Leber congenital amaurosis, according to a press release from Opus Genetics.

MCO-010 demonstrated positive topline results in vision improvement in patients with permanent and severe vision loss from advanced retinitis pigmentosa, according to a press release from Nanoscope Therapeutics.

Looking directly at the sun is never safe, but the temptation is high during a rare event like a solar eclipse.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Kent W. Small, MD, discusses research exploring non-coding mutations in North Carolina macular dystrophy.

Patients with neovascular age-related macular degeneration experienced visual benefits and anatomic improvements with extended dosing intervals of IBI302, according to a press release from Innovent Biologics.

In the dynamic landscape of diabetic macular edema management, the PALADIN study continues to offer helpful insights into the outcomes of IOP-lowering surgery after treatment with Iluvien.